Amneal Pharmaceuticals Inc Class A (AMRX)
EBITDA Margin
24.34%
Quarterly · Period ending:
AMRX EBITDA Margin
Latest reported24.34%period ending
Latest reported24.34%period ending
AMRX Quarterly EBITDA Margin (34.17% → 24.34%)
Quarterly ebitda margin
High-resolution chart · PNG
AMRX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 24.3382% | |
| 25.7517% | |
| 19.7342% | |
| 14.2335% | |
| 24.42% | |
| 22.2289% | |
| 15.3963% | |
| 19.9148% | |
| 20.1909% | |
| 6.9341% | |
| 5.3519% | |
| 21.1393% | |
| 22.9745% | |
| 17.5842% | |
| 16.4703% | |
| 19.4625% | |
| -24.5662% | |
| 16.3231% | |
| 14.6809% | |
| 17.5074% | |
| 23.435% | |
| 21.1594% | |
| 17.4363% | |
| 13.9353% | |
| 15.7067% | |
| 22.3307% | |
| 9.0658% | |
| 32.2095% | |
| 9.4812% | |
| -9.1973% | |
| 15.1885% | |
| 27.0096% | |
| -43.7573% | |
| 31.0478% | |
| 39.2223% | |
| 28.0745% | |
| 26.1137% | |
| 23.6298% | |
| 34.1658% |